KYNU and schizophrenia: Considering that KMO is already impaired in individuals with schizophrenia (Figure 5A), one may suggest that the inhibition of KAT would increase Kyn availability as a substrate for kynureninase, consequently leading to a robust increase in AA formation [80,81] (Figure 5B).